#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	26670	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2161	1213.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	1483	C,T	1426,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	26670	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2161	1213.3	0	HET	.	.	.	C451T,G	.	451	451	C	676	676	C	1495	C,T,G	1081,361,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	26670	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2161	1213.3	0	HET	.	.	.	C207T,G	.	207	207	C	432	432	C	1458	C,T,G	753,624,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	49838	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3469	1417.5	0	.	n	.	0	T695C	SNP	695	695	T	1043	1043	C	1494	C,G	1441,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	49838	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3469	1417.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2319	2319	C	1511	C	1435	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	49838	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3469	1417.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2393	2393	A	1479	A,G	1428,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	49838	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3469	1417.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2945	2945	C	1509	C	1449	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	49838	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3469	1417.5	0	HET	.	.	.	A1638G	.	1638	1638	A	1986	1986	A	1552	A,G	1148,353	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	3436	folP	855	855	100.0	folP.l15.c4.ctg.1	1402	241.2	1	SNP	p	R229S	1	.	.	685	687	AGC	955	957	AGC	315;314;313	A;G;C	297;303;297	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	10338	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3432	297.5	1	SNP	p	S91F	1	.	.	271	273	TTC	617	619	TTC	338;338;337	T,C;T;C	325,1;327;326	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	10338	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3432	297.5	1	SNP	p	D95G	1	.	.	283	285	GGC	629	631	GGC	327;326;325	G;G,A;C	315;312,1;314	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	10338	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3432	297.5	1	SNP	p	G95N	0	.	.	283	285	GGC	629	631	GGC	327;326;325	G;G,A;C	315;312,1;314	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2990	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1343	220.2	1	SNP	p	G45D	0	.	.	133	135	GGC	457	459	GGC	386;382;383	G;G;C	370;370;370	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1644	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1042	155.8	0	.	n	.	0	A197.	DEL	197	197	A	603	603	A	383	A	370	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8786	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3018	287.3	1	SNP	p	D86N	0	.	.	256	258	GAC	645	647	GAC	347;348;351	G;A;C	332;327;336	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8786	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3018	287.3	1	SNP	p	R87W	0	.	.	259	261	CGT	648	650	CGT	352;349;349	C;G;T	338;334;331	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8786	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3018	287.3	1	SNP	p	R87I	0	.	.	259	261	CGT	648	650	CGT	352;349;349	C;G;T	338;334;331	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8786	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3018	287.3	1	SNP	p	S87R	1	.	.	259	261	CGT	648	650	CGT	352;349;349	C;G;T	338;334;331	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8786	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3018	287.3	1	SNP	p	S88P	0	.	.	262	264	TCC	651	653	TCC	351;350;349	T;C;C	333;332;329	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	7602	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2697	278.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1563	1565	GGC	387;382;382	G;G;C	371;363;363	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	7440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2372	309.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1270	1272	GCC	429;427;426	G;C;C	407;403;403	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2372	309.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1273	1275	ATG	435;435;431	A;T;G,C	413;415;408,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2372	309.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1285	1287	ACC	420;419;420	A,C;C;C	393,1;405;405	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2372	309.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1285	1287	ACC	420;419;420	A,C;C;C	393,1;405;405	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2372	309.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1786	1788	ACC	364;367;370	A;C;C	342;354;361	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2372	309.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1840	1842	GCG	342;344;344	G;C;G	327;330;332	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2372	309.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1840	1842	GCG	342;344;344	G;C;G	327;330;332	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2372	309.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1963	1965	GGT	284;281;282	G;G;T	273;268;269	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2372	309.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1972	1974	AGC	263;261;259	A;G;C,G	249;253;249,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	7440	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2372	309.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1990	1992	CCG	203;205;208	C,G;C,G,T;G	181,6;179,2,1;183	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	10350	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3175	322.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1661	1663	CCG	364;364;363	C;C,T;G,A	333;345,1;329,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	4498	porA	1146	1146	99.91	porA.l15.c30.ctg.1	1912	231.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	575	575	C	326	C,G	308,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4834	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1550	307.2	0	.	p	.	0	S217N	NONSYN	649	651	AGT	932	934	AAT	390;390;387	A;A,G;T	374;375,1;372	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4834	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1550	307.2	1	SNP	p	G120K	1	.	.	358	360	AAG	641	643	AAG	380;383;380	A,G;A,G;G,T	366,2;374,1;357,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4834	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1550	307.2	1	SNP	p	A121N	1	.	.	361	363	AAC	644	646	AAC	385;385;389	A,G;A,C;C	375,2;373,2;379	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4834	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1550	307.2	1	SNP	p	N121D	0	.	.	361	363	AAC	644	646	AAC	385;385;389	A,G;A,C;C	375,2;373,2;379	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	16870	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4890	340.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1974	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1027	190.0	1	SNP	p	V57M	1	.	.	169	171	ATG	509	511	ATG	409;411;403	A;T;G	398;399;392	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
